• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Age is an important prognostic factor in COVID-19 patients treated with extracorporeal membrane oxygenation.

作者信息

Lee Song-I, Kang Da Hyun, Ahn Hong Joon, Kim Mi Joo, Shim Man-Shik, Lee Jeong Eun

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Republic of Korea.

Department of Emergency Medicine, College of Medicine, Chungnam National University School of Medicine, Daejeon, Republic of Korea.

出版信息

J Thorac Dis. 2022 Aug;14(8):3094-3097. doi: 10.21037/jtd-22-493.

DOI:10.21037/jtd-22-493
PMID:36071774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9442505/
Abstract
摘要

相似文献

1
Age is an important prognostic factor in COVID-19 patients treated with extracorporeal membrane oxygenation.年龄是接受体外膜肺氧合治疗的COVID-19患者的一个重要预后因素。
J Thorac Dis. 2022 Aug;14(8):3094-3097. doi: 10.21037/jtd-22-493.
2
Treatment of acute respiratory distress syndrome from COVID-19 with extracorporeal membrane oxygenation in obstetrical patients.产科患者中使用体外膜肺氧合治疗新型冠状病毒肺炎所致急性呼吸窘迫综合征
Am J Obstet Gynecol MFM. 2022 Mar;4(2):100537. doi: 10.1016/j.ajogmf.2021.100537. Epub 2021 Nov 20.
3
Organization of extracorporeal membrane oxygenation services for COVID-19.COVID-19 体外膜肺氧合服务的组织。
Asian Cardiovasc Thorac Ann. 2021 Mar;29(3):165-169. doi: 10.1177/0218492320962932. Epub 2020 Sep 30.
4
Efficacy of extracorporeal membrane oxygenation for acute respiratory failure with interstitial lung disease: a case control nationwide dataset study in Japan.体外膜肺氧合治疗间质性肺疾病所致急性呼吸衰竭的疗效：日本全国病例对照数据集研究。
Respir Res. 2021 Jul 24;22(1):211. doi: 10.1186/s12931-021-01805-w.
5
Posthospitalization outcomes after extracorporeal membrane oxygenation (ECMO) for COVID-19.COVID-19 患者体外膜肺氧合（ECMO）后的住院后结局。
Surgery. 2022 Jul;172(1):466-469. doi: 10.1016/j.surg.2022.01.044. Epub 2022 Feb 8.
6
Rehabilitation for COVID-19 in conjunction with early awake extracorporeal membrane oxygenation support: a case report.COVID-19 康复治疗联合早期清醒体外膜肺氧合支持：病例报告。
Int J Rehabil Res. 2022 Sep 1;45(3):287-290. doi: 10.1097/MRR.0000000000000533. Epub 2022 Jun 22.
7
Use of Extracorporeal Membrane Oxygenation Therapy During Pregnancy and COVID-19: A Case Study.妊娠期使用体外膜肺氧合治疗COVID-19：病例研究。
AACN Adv Crit Care. 2022 Sep 15;33(3):247-252. doi: 10.4037/aacnacc2022111.
8
Neurologic outcome in children after extracorporeal membrane oxygenation: prognostic value of diagnostic tests.儿童体外膜肺氧合后的神经学转归：诊断性检查的预后价值
Pediatr Neurol. 2005 Mar;32(3):173-9. doi: 10.1016/j.pediatrneurol.2004.10.002.
9
Veno-venous extracorporeal membrane oxygenation for COVID-19-associated pediatric acute respiratory distress syndrome.用于新型冠状病毒肺炎相关儿童急性呼吸窘迫综合征的静脉-静脉体外膜肺氧合
Perfusion. 2020 Sep;35(6):550-553. doi: 10.1177/0267659120939757. Epub 2020 Jul 9.
10
COVID-19 and Extracorporeal Membrane Oxygenation.新型冠状病毒肺炎与体外膜肺氧合
Adv Exp Med Biol. 2021;1353:173-195. doi: 10.1007/978-3-030-85113-2_10.

引用本文的文献

1
SARS-CoV-2 Pneumonia: Advances in Diagnosis and Treatment.严重急性呼吸综合征冠状病毒2型肺炎：诊断与治疗进展
Microorganisms. 2025 Jul 31;13(8):1791. doi: 10.3390/microorganisms13081791.
2
Relationship between the Pre-ECMO and ECMO Time and Survival of Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.体外膜肺氧合（ECMO）治疗前时间和ECMO治疗时间与重症新型冠状病毒肺炎（COVID-19）患者生存的关系：一项系统评价和荟萃分析
J Clin Med. 2024 Feb 1;13(3):868. doi: 10.3390/jcm13030868.

本文引用的文献

1
Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.体外膜肺氧合治疗 COVID-19 的系统评价和荟萃分析。
Crit Care. 2021 Jun 14;25(1):211. doi: 10.1186/s13054-021-03634-1.
2
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study.体外膜肺氧合网络组织与 COVID-19 大流行期间法国大巴黎地区的临床结局：一项多中心队列研究。
Lancet Respir Med. 2021 Aug;9(8):851-862. doi: 10.1016/S2213-2600(21)00096-5. Epub 2021 Apr 19.
3
Mortality Risk Assessment in COVID-19 Venovenous Extracorporeal Membrane Oxygenation.COVID-19 患者行静脉-静脉体外膜肺氧合的死亡率评估。
Ann Thorac Surg. 2021 Dec;112(6):1983-1989. doi: 10.1016/j.athoracsur.2020.12.050. Epub 2021 Jan 21.
4
ECMO for severe ARDS: systematic review and individual patient data meta-analysis.体外膜肺氧合治疗严重急性呼吸窘迫综合征：系统评价和个体患者数据荟萃分析。
Intensive Care Med. 2020 Nov;46(11):2048-2057. doi: 10.1007/s00134-020-06248-3. Epub 2020 Oct 6.
5
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.COVID-19 患者的体外膜肺氧合支持：体外生命支持组织登记处的国际队列研究。
Lancet. 2020 Oct 10;396(10257):1071-1078. doi: 10.1016/S0140-6736(20)32008-0. Epub 2020 Sep 25.
6
Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis.静脉-静脉体外膜肺氧合治疗急性呼吸窘迫综合征：系统评价和荟萃分析。
Lancet Respir Med. 2019 Feb;7(2):163-172. doi: 10.1016/S2213-2600(18)30452-1. Epub 2019 Jan 11.
7
Age is major factor for predicting survival in patients with acute respiratory failure on extracorporeal membrane oxygenation: a Korean multicenter study.年龄是预测接受体外膜肺氧合治疗的急性呼吸衰竭患者生存率的主要因素：一项韩国多中心研究。
J Thorac Dis. 2018 Mar;10(3):1406-1417. doi: 10.21037/jtd.2018.03.71.
8
Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score.体外膜肺氧合治疗严重急性呼吸衰竭患者的预后预测。呼吸体外膜肺氧合生存预测（RESP）评分。
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1374-82. doi: 10.1164/rccm.201311-2023OC.
9
Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center.接受体外膜肺氧合治疗并转诊至某转诊中心的急性呼吸窘迫综合征患者的治疗结果
Intensive Care Med. 2014 Jan;40(1):74-83. doi: 10.1007/s00134-013-3135-1. Epub 2013 Oct 30.
10
The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome.体外膜肺氧合治疗严重急性呼吸窘迫综合征的 PRESERVE 死亡率评分和长期预后分析。
Intensive Care Med. 2013 Oct;39(10):1704-13. doi: 10.1007/s00134-013-3037-2. Epub 2013 Aug 2.